286 related articles for article (PubMed ID: 30108174)
1. LEM domain-containing protein 3 antagonizes TGFβ-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol.
Chambers DM; Moretti L; Zhang JJ; Cooper SW; Chambers DM; Santangelo PJ; Barker TH
J Biol Chem; 2018 Oct; 293(41):15867-15886. PubMed ID: 30108174
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
[TBL] [Abstract][Full Text] [Related]
3. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling.
Lin F; Morrison JM; Wu W; Worman HJ
Hum Mol Genet; 2005 Feb; 14(3):437-45. PubMed ID: 15601644
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
5. Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway.
Kato M; Takahashi F; Sato T; Mitsuishi Y; Tajima K; Ihara H; Nurwidya F; Baskoro H; Murakami A; Kobayashi I; Hidayat M; Shimada N; Sasaki S; Mineki R; Fujimura T; Kumasaka T; Niwa SI; Takahashi K
Drug Des Devel Ther; 2020; 14():4593-4603. PubMed ID: 33149556
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for receptor-regulated SMAD recognition by MAN1.
Miyazono KI; Ohno Y; Wada H; Ito T; Fukatsu Y; Kurisaki A; Asashima M; Tanokura M
Nucleic Acids Res; 2018 Dec; 46(22):12139-12153. PubMed ID: 30321401
[TBL] [Abstract][Full Text] [Related]
8. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
Tu AW; Luo K
J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422
[TBL] [Abstract][Full Text] [Related]
9. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.
Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH
Cell; 2006 Jun; 125(5):915-28. PubMed ID: 16751101
[TBL] [Abstract][Full Text] [Related]
10. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.
Wrighton KH; Willis D; Long J; Liu F; Lin X; Feng XH
J Biol Chem; 2006 Dec; 281(50):38365-75. PubMed ID: 17035229
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription.
García-Vizcaíno EM; Liarte S; Alonso-Romero JL; Nicolás FJ
Cell Commun Signal; 2017 Nov; 15(1):50. PubMed ID: 29187201
[TBL] [Abstract][Full Text] [Related]
12. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling.
Dai F; Lin X; Chang C; Feng XH
Dev Cell; 2009 Mar; 16(3):345-57. PubMed ID: 19289081
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
15. Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.
Hoover LL; Burton EG; O'Neill ML; Brooks BA; Sreedharan S; Dawson NA; Kubalak SW
Biochim Biophys Acta; 2008 Dec; 1783(12):2279-86. PubMed ID: 18773928
[TBL] [Abstract][Full Text] [Related]
16. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.
Bu S; Kapanadze B; Hsu T; Trojanowska M
J Biol Chem; 2008 Jul; 283(28):19593-602. PubMed ID: 18482992
[TBL] [Abstract][Full Text] [Related]
18. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
[TBL] [Abstract][Full Text] [Related]
20. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.
Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH
Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
